The US Food and Drug Administration (FDA) has approved a new drug for the treatment of Alzheimer’s disease — the first of its kind for twenty years. What does this mean for those affected by Alzheimer’s disease in India? Aducanumab, from the company Biogen, is a monoclonal antibody that aims to slow the gradual progression […]
Alzheimer's disease
Could COVID-19 lead to a greater dementia risk?
COVID-19, at least at a surface level, seems all but entirely disconnected from conditions such as dementia — besides its evident effect on those who suffer from the condition. However, could there be a link between the two conditions? Dementia is an umbrella term that encompasses a number of neurological conditions in which aspects of […]
Retinal scans and AI: Tools in fighting Alzheimer’s?
New research suggests retinal scans and artificial intelligence (AI) could play a part in fighting Alzheimer’s disease. The research – published in The British Journal of Ophthalmology – indicated that computer software using a novel form of AI “was able to successfully identify a group of patients who were known to have Alzheimer’s disease…the novel […]
Alzheimer’s disease: The view from India
Alzheimer’s disease is a significant public health crisis in India, one which afflicts millions. Alzheimer’s disease is one of the most common forms of dementia, “a syndrome in which there is deterioration in memory, thinking, behaviour and the ability to perform everyday activities” as explained by the World Health Organization (WHO). The WHO notes that […]